CYCN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 36.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Cyclerion Therapeutics Insider Trading History Chart

Cyclerion Therapeutics Share Price & Price History

^$2.58

▼ -0.03 (-1.15%)

As of 04/3/2025 05:00 PM ET

Days: 30 | 90 | 365

Cyclerion Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/9/2023	Terrance Mcguire	Director	Sell	8	$3.40	$27.20	552

SEC Filings (Institutional Ownership Changes) for Cyclerion Therapeutics (NASDAQ:CYCN)

75.62% of Cyclerion Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cyclerion Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/13/2025	Renaissance Technologies LLC	10,611	$34K	0.0%	N/A	0.392%
2/14/2024	Tyndall Capital Partners L P	164,429	$0.55M	100.0%	+11.3%	6.711%
11/14/2023	Tyndall Capital Partners L P	147,712	$0.51M	100.0%	N/A	6.129%
8/11/2023	Artal Group S.A.	138,955	$0.57M	0.0%	-95.0%	5.766%
5/9/2022	Trustcore Financial Services LLC	292,645	$0.33M	0.0%	+47.7%	0.674%
2/14/2022	Diametric Capital LP	100,480	$0.17M	0.1%	+43.9%	0.232%
2/10/2022	Acadian Asset Management LLC	249,792	$0.43M	0.0%	N/A	0.577%
11/16/2021	Two Sigma Advisers LP	647,700	$1.99M	0.0%	+98.4%	1.495%
11/16/2021	Two Sigma Investments LP	390,596	$1.20M	0.0%	+154.1%	0.902%
11/15/2021	Pura Vida Investments LLC	422,311	$1.30M	0.0%	-16.8%	0.975%
11/15/2021	Eversept Partners LP	371,955	$1.14M	0.1%	N/A	0.859%
11/15/2021	Franklin Resources Inc.	116,035	$0.36M	0.0%	N/A	0.268%
11/12/2021	Jump Financial LLC	52,000	$0.16M	0.0%	N/A	0.120%
11/12/2021	Geode Capital Management LLC	490,660	$1.51M	0.0%	+27.5%	1.134%
9/17/2021	Virtu Financial LLC	80,384	$0.31M	0.0%	-9.2%	0.186%
9/3/2021	Parametric Portfolio Associates LLC	12,596	$49K	0.0%	-52.0%	0.029%
8/25/2021	Marshall Wace LLP	28,863	$0.11M	0.0%	N/A	0.067%
8/18/2021	Ikarian Capital LLC	509,924	$1.99M	0.2%	+70.0%	1.178%
8/17/2021	Millennium Management LLC	389,041	$1.52M	0.0%	N/A	0.899%
8/17/2021	Boothbay Fund Management LLC	66,977	$0.26M	0.0%	+96.3%	0.155%
8/16/2021	Cubist Systematic Strategies LLC	17,084	$67K	0.0%	N/A	0.039%
8/16/2021	Diametric Capital LP	80,336	$0.31M	0.2%	N/A	0.186%
8/16/2021	Slate Path Capital LP	7,157,601	$27.92M	1.6%	+15.5%	16.539%
8/16/2021	Charles Schwab Investment Management Inc.	129,628	$0.51M	0.0%	-35.1%	0.300%
8/16/2021	State Street Corp	83,321	$0.33M	0.0%	-79.2%	0.193%
8/16/2021	Tibra Equities Europe Ltd	85,000	$0.33M	0.1%	N/A	0.196%
8/16/2021	Goldman Sachs Group Inc.	36,317	$0.14M	0.0%	-9.4%	0.084%
8/16/2021	Marshall Wace LLP	28,863	$0.11M	0.0%	N/A	0.067%
8/13/2021	Renaissance Technologies LLC	284,744	$1.11M	0.0%	+22.1%	0.658%
8/13/2021	Northern Trust Corp	64,616	$0.25M	0.0%	-73.0%	0.149%
8/13/2021	Geode Capital Management LLC	384,820	$1.50M	0.0%	-21.0%	0.889%
8/13/2021	Vanguard Group Inc.	1,423,532	$5.55M	0.0%	-14.7%	3.289%
8/13/2021	FMR LLC	2,674,811	$10.43M	0.0%	-1.9%	6.181%
8/12/2021	Prime Capital Investment Advisors LLC	22,250	$87K	0.0%	N/A	0.051%
8/12/2021	XTX Topco Ltd	17,968	$70K	0.0%	+34.4%	0.042%
8/12/2021	Dimensional Fund Advisors LP	158,994	$0.62M	0.0%	+160.1%	0.367%
8/12/2021	JPMorgan Chase & Co.	59,786	$0.23M	0.0%	-43.7%	0.138%
8/12/2021	Ergoteles LLC	96,100	$0.38M	0.0%	N/A	0.222%
8/11/2021	Bank of New York Mellon Corp	66,792	$0.26M	0.0%	-31.9%	0.154%
8/11/2021	Deutsche Bank AG	65,900	$0.26M	0.0%	-18.7%	0.152%
8/11/2021	Susquehanna Fundamental Investments LLC	105,572	$0.41M	0.0%	N/A	0.244%
5/19/2021	Virtu Financial LLC	88,551	$0.25M	0.0%	N/A	0.259%
5/18/2021	D. E. Shaw & Co. Inc.	68,472	$0.19M	0.0%	-62.2%	0.201%
5/17/2021	PDT Partners LLC	42,900	$0.12M	0.0%	+74.4%	0.126%
5/17/2021	Walleye Trading LLC	10,000	$28K	0.0%	N/A	0.029%
5/17/2021	Walleye Capital LLC	15,000	$42K	0.0%	N/A	0.044%
5/17/2021	Ikarian Capital LLC	300,000	$0.84M	0.0%	N/A	0.879%
5/14/2021	XTX Topco Ltd	13,365	$37K	0.0%	N/A	0.039%
5/13/2021	QS Investors LLC	116,035	$0.32M	0.0%	+13.1%	0.340%
5/13/2021	Barclays PLC	18,516	$52K	0.0%	+159.0%	0.054%
5/13/2021	Renaissance Technologies LLC	233,200	$0.65M	0.0%	+1,202.8%	0.683%
5/12/2021	Northern Trust Corp	239,015	$0.67M	0.0%	-7.0%	0.700%
5/12/2021	Geode Capital Management LLC	486,959	$1.36M	0.0%	+12.2%	1.427%
5/12/2021	JPMorgan Chase & Co.	106,102	$0.30M	0.0%	+19.1%	0.311%
5/11/2021	New York State Common Retirement Fund	12,070	$34K	0.0%	-91.0%	0.035%
5/10/2021	Russell Investments Group Ltd.	124,075	$0.35M	0.0%	+400.2%	0.363%
5/10/2021	Bank Julius Baer & Co. Ltd Zurich	12,000	$33K	0.0%	-33.2%	0.035%
5/7/2021	BlackRock Inc.	1,685,485	$4.70M	0.0%	+5.1%	4.938%
4/28/2021	DAVENPORT & Co LLC	84,500	$0.24M	0.0%	+369.0%	0.248%
3/8/2021	Dimensional Fund Advisors LP	63,735	$0.20M	0.0%	+8.7%	0.187%
3/1/2021	UBS Asset Management Americas Inc.	10,149	$31K	0.0%	-58.8%	0.030%
2/25/2021	Dimensional Fund Advisors LP	63,735	$0.20M	0.0%	+8.7%	0.188%
2/24/2021	Bank Julius Baer & Co. Ltd Zurich	17,974	$55K	0.0%	N/A	0.053%
2/19/2021	JPMorgan Chase & Co.	89,079	$0.27M	0.0%	+84.8%	0.262%
2/16/2021	Charles Schwab Investment Management Inc.	177,091	$0.54M	0.0%	-6.5%	0.521%
2/11/2021	Northern Trust Corp	257,044	$0.79M	0.0%	-3.4%	0.757%
2/10/2021	Rhumbline Advisers	34,065	$0.10M	0.0%	+15.8%	0.100%
2/10/2021	Renaissance Technologies LLC	17,900	$55K	0.0%	N/A	0.053%
2/9/2021	Wells Fargo & Company MN	50,522	$0.15M	0.0%	+77.9%	0.149%
2/9/2021	Bank of New York Mellon Corp	100,061	$0.31M	0.0%	+13.2%	0.295%

Data available starting January 2016

See Full Table

Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to out-license for cardiovascular diseases; and Praliciguat, a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $2.58

$2.49

$2.65

50 Day Range

MA: $2.92

$2.37

$5.32

52 Week Range

Now: $2.58

$1.27

$9.47

Volume

23,630 shs

Average Volume

1,305,315 shs

Market Capitalization

$6.99 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.96

Who are the company insiders with the largest holdings of Cyclerion Therapeutics?: Cyclerion Therapeutics' top insider shareholders include:
Terrance Mcguire (Director)
Learn More about top insider investors at Cyclerion Therapeutics.